Assessment of pain-related behaviors in the TNBS treated mice, includes a hypersensitive withdrawal responses from tactile stimuli applied to the abdomen as a type of pain-stimulated behavior in mice; however, in contrast to the clinical contraindication of MOR agonists for IBD treatment, morphine reduced this tactile hypersensitivity (21). The gene discussed is OPRM1; the disease is inflammatory bowel disease.